Parasitic Diseases
Parasitic Diseases |
|
| The cluster focuses on research on a number of parasitic diseases, majority of which affects the poor of the society. The main focus areas are developing new and/or improved diagnostics which encompass protein and DNA-based tests; isolation and genotyping of local parasite strains and screening for anti-parasitic compounds. The cluster performs basic research to advance scientific knowledge; translational research to develop prototype diagnostic tests, evaluation studies to validate the findings, as well as operational research to assist in the disease elimination program. Studies on discovery of new infections markers involve the following diseases: toxoplasmosis, lymphatic filariasis, extraintestinal amoebiasis, strongyloidiasis, hydatid disease, malaria and toxocariasis. Research outcomes from this cluster include publications, patents and commercialization of diagnostic tests and specialized diagnostic services. Some of the products such as Brugia Rapid and panLF Rapid lateral flow rapidtests (http://www.reszonics.com/product3.html) have been recognised by the World Health Organization (WHO) for use in detecting Brugian filariasis, which is endemic in certain countries as part of the global programme for elimination of lymphatic filariasis (GPELF). | |
| Contact Person: Professor Rahmah Nordin Institute for Research on Molecular Medicine |
|
 |
rahmah8485 @ gmail.com |